This study demonstrates that streptomyces ahygroscopicus var. gongzhulingensis shows significant antifungal effects, highlighting its potential for managing sclerotinia rot.
Introduction Sunflower sclerotinia rot caused by Sclerotinia sclerotiorum poses a significant threat to global agriculture. This study investigates Streptomyces ahygroscopicus var. gongzhulingensis 769 (S769) as a novel biocontrol agent against this devastating disease. Methods Antagonism assays evaluated S769's efficacy in vitro, while detached leaf, pot, and field trials assessed disease suppression through soil mixing (S769-Ms) and root drenching (S769-i). Mechanistic analyses included enzyme activity assays, microbiome profiling, qPCR quantification of pathogen load, and root transcriptomics. Results S769 exhibited 65.79% mycelial growth inhibition in vitro. Field trials demonstrated significant disease control (S769-Ms: 7.36%, S769-i: 5.92% vs. 14.69% control), with 15.85% increase in root fresh weight and 34.26% reduction in shriveled seeds. qPCR confirmed 4.85-fold pathogen reduction in leaves and 2.68-fold in roots. Transcriptomics revealed 6,622 upregulated genes, including MAPK signaling and phenylpropanoid biosynthesis pathways. Discussion S769 demonstrates dual action through direct antifungal effects and host defense activation. The enrichment of beneficial rhizobacteria (Sphingomonas, Chitinophagaceae) without altering microbial diversity highlights its potential as a sustainable agricultural solution for sclerotinia rot management.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: